Protein transduction from retroviral Gag precursors.
Retroviral particles assemble a few thousand units of the Gag polyproteins. Proteolytic cleavage mediated by the retroviral protease forms the bioactive retroviral protein subunits before cell entry. We hypothesized that this process could be exploited for targeted, transient, and dose-controlled transduction of nonretroviral proteins into cultured cells. We demonstrate that gammaretroviral particles tolerate the incorporation of foreign protein at several positions of their Gag or Gag-Pol precursors. Receptor-mediated and thus potentially cell-specific uptake of engineered particles occurred within minutes after cell contact. Dose and kinetics of nonretroviral protein delivery were dependent upon the location within the polyprotein precursor. Proteins containing nuclear localization signals were incorporated into retroviral particles, and the proteins of interest were released from the precursor by the retroviral protease, recognizing engineered target sites. In contrast to integration-defective lentiviral vectors, protein transduction by retroviral polyprotein precursors was completely transient, as protein transducing retrovirus-like particles could be produced that did not transduce genes into target cells. Alternatively, bifunctional protein-delivering particle preparations were generated that maintained their ability to serve as vectors for retroviral transgenes. We show the potential of this approach for targeted genome engineering of induced pluripotent stem cells by delivering the site-specific DNA recombinase, Flp. Protein transduction of Flp after proteolytic release from the matrix position of Gag allowed excision of a lentivirally transduced cassette that concomitantly expresses the canonical reprogramming transcription factors (Oct4, Klf4, Sox2, c-Myc) and a fluorescent marker gene, thus generating induced pluripotent stem cells that are free of lentivirally transduced reprogramming genes.
Voelkel
Christine
C
Department of Experimental Hematology, and Research Group Stem Cell Biology, Hannover Medical School, D-30625 Hannover, Germany.
Galla
Melanie
M
Maetzig
Tobias
T
Warlich
Eva
E
Kuehle
Johannes
J
Zychlinski
Daniela
D
Bode
Juergen
J
Cantz
Tobias
T
Schambach
Axel
A
Baum
Christopher
C
D015683:Gene Products, gag / Q000096:biosynthesis* / Q000235:genetics; D005818:Genetic Engineering / Q000379:methods; D049452:Green Fluorescent Proteins / Q000378:metabolism; D007700:Kinetics; D009052:Leukemia Virus, Murine / Q000235:genetics / Q000378:metabolism*; D019913:Nuclear Localization Signals / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism; D014161:Transduction, Genetic / Q000379:methods*; D014771:Virion / Q000235:genetics / Q000378:metabolism*; D053586:Virus Internalization
D015683:Gene Products, gag; D019913:Nuclear Localization Signals; D049452:Green Fluorescent Proteins; D010447:Peptide Hydrolases
J Virol. 2007 Jun;81(12):6623-31
17392359
J Virol. 2008 Mar;82(6):3069-77
18199655
Curr Opin Mol Ther. 2007 Oct;9(5):423-31
17932806
PLoS One. 2007 Jan 17;2(1):e162
17225864
J Virol. 2003 Nov;77(21):11651-60
14557651
Science. 1999 Sep 3;285(5433):1569-72
10477521
Blood. 2005 Nov 15;106(10):3386-95
16076865
Mol Ther. 2000 May;1(5 Pt 1):448-56
10933966
J Virol. 2006 Oct;80(19):9497-510
16973554
Retrovirology. 2007 Sep 10;4:63
17845727
Mol Ther. 2006 Jun;13(6):1121-32
16556511
Gene Ther. 2006 Nov;13(21):1524-33
16763662
Mol Cell. 2004 Oct 22;16(2):309-15
15494317
Mol Ther. 2006 Feb;13(2):391-400
16226060
J Immunol. 2009 May 1;182(9):5633-40
19380810
Mol Ther. 2006 Jun;13(6):1050-63
16632409
Cell. 2006 Aug 25;126(4):663-76
16904174
Trends Biotechnol. 2009 May;27(5):259-65
19327858
Cytotechnology. 2006 Mar;50(1-3):93-108
19003073
J Virol. 2004 Feb;78(3):1411-20
14722296
Nat Biotechnol. 2009 Aug;27(8):743-5
19590502
Virology. 1999 Mar 1;255(1):20-5
10049817
J Virol. 2007 Nov;81(22):12596-607
17728233
Trends Mol Med. 2007 Oct;13(10):443-8
17913584
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8
16230638
Genes Dev. 1989 Apr;3(4):469-78
2721960
J Virol. 1995 Aug;69(8):4600-6
7609024
Mol Ther. 2007 Mar;15(3):457-66
17245356
Cell. 2009 Mar 6;136(5):964-77
19269371
Nucleic Acids Res. 2006 Jan 30;34(2):e16
16449199
Exp Hematol. 2006 May;34(5):588-92
16647564
Traffic. 2003 Nov;4(11):785-801
14617360
Hum Gene Ther. 2010 May;21(5):589-602
20039782
Gene Ther. 2001 Jan;8(1):1-4
11402295
Virology. 2000 Mar 15;268(2):364-71
10704344
Nat Biotechnol. 2001 Dec;19(12):1173-6
11731788
J Virol. 2004 Oct;78(19):10803-13
15367647
Immunol Rev. 2004 Jun;199:251-63
15233739
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11678-83
14504385
Blood. 2002 Aug 1;100(3):823-32
12130492
J Gene Med. 2005 Apr;7(4):389-97
15619289
J Biol Chem. 1994 Apr 8;269(14):10444-50
8144628
PLoS Pathog. 2007 May 25;3(5):e74
17530924
Nat Med. 2006 Mar;12(3):348-53
16491086
J Cell Biol. 2002 Nov 11;159(3):441-52
12417576
J Mol Biol. 2009 Jul 24;390(4):579-94
19447116
Virology. 2007 Mar 30;360(1):92-104
17097708
Virology. 2007 Apr 10;360(2):286-93
17123568
Stem Cells. 2010 Jan;28(1):64-74
19904830
Hum Gene Ther. 2004 Apr;15(4):361-72
15053861
Nat Biotechnol. 2002 Nov;20(11):1151-4
12355096
Blood. 2008 Dec 15;112(13):4843-52
18812471
Annu Rev Genet. 1992;26:527-44
1482125